Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection

被引:25
作者
Blank, M
Shani, A
Goldberg, I
Kopolovic, J
Amigo, MC
Magrini, L
Shoenfeld, Y [1 ]
机构
[1] Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-52621 Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Tel Hashomer, Israel
[5] Inst Nacl Cardiol Ignacio Chavez, Dept Rheumatol, Mexico City, DF, Mexico
[6] Univ Roma La Sapienza, Dept Clin & Therapeut Appl Med, Rome, Italy
[7] Tel Aviv Univ, Laura Schwarz Kipp Chair Autoimmun, IL-69978 Tel Aviv, Israel
关键词
Libman-Sacks endocarditis; beta-2-glycoprotein-I; synthetic peptides; antiphospholipid syndrome;
D O I
10.1016/j.thromres.2004.06.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Anti phospholipid syndrome (APS) is a systemic autoimmune disease, associated not only with a hypercoagulable state and recurrent fetal loss but with many diverse clinical manifestations including heart involvement, neurological manifestations, as well as skin, kidney and hematologic abnormalities. Cardiac manifestations include coronary by-pass graft and angioplasty occlusions, cardiomyopathy, cyanotic congenital heart disease, intracardiac thrombus and complications of cardiovascular surgery. The valvular heart disease was defined as Libman-Sacks nonbacterial endocarditis. Previously, we have shown a linear subendothelial deposition of anti-cardiotipin/beta(2) glycoprotein I (beta 2GPI) antibodies in the valve specimens derived from APS patients. The involvement of complement C3c in the pathogenesis was documented. We assessed the beta 2GPI-related target epitope recognized by the anti-beta 2GPI Abs on the valves. Materials and methods: In order to find the beta 2GPI-retated target epitopes recognized by the anti-beta 2GPI antibodies on the valves, we used beta 2GPI-related synthetic peptides. The presence of anti-beta 2GPI Abs on the studied valves was detected by anti-idiotypic antibody, followed by immunoperoxidase analysis. Biotin attached to the N-terminal of beta 2GPI-related synthetic peptides and control peptide were used to identify the epitope addressed by the anti-beta 2GPI Abs deposited on the patient's valve. The binding was probed by streptavidin-peroxidase and appropriate substrate. The specificity was confirmed by competition assays with control peptide and anti-idiotypic antibody. Results: Among the beta 2GPI-retated synthetic peptides, two peptides were found in previous studies to mimic common pathogens either bacteriae or viruses, which raised a possible infectious origin for APS. One of these peptides, TLRVYK, is a specific target for anti-beta 2GPI Abs deposited on the APS valves. This synthetic peptide was able to displace the anti-anti-beta 2GPI anti-idiotypic Abs for binding the anti-beta 2GPI Abs on the valve by a competition assay. Conclusion: We point to the possibility that Libman-Sacks nonbacterial endocarditis may have an infectious origin. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:589 / 592
页数:4
相关论文
共 30 条
[1]   Increased endothelial cell expression of α3β1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome [J].
Afek, A ;
Shoenfeld, Y ;
Manor, R ;
Goldberg, I ;
Ziporen, L ;
George, J ;
Polak-Charcon, S ;
Amigo, MC ;
Garcia-Torres, R ;
Segal, R ;
Kopolovic, J .
LUPUS, 1999, 8 (07) :502-507
[2]  
ASHERSON RA, 1989, CLIN EXP RHEUMATOL, V7, P225
[3]   Unusual manifestations of the antiphospholipid syndrome [J].
Asherson, RA ;
Cervera, R .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2003, 25 (01) :61-77
[4]  
Asherson RA, 2002, ANTIPHOSPHOLIPID SYN
[5]   Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides [J].
Blank, M ;
Shoenfeld, Y ;
Cabilly, S ;
Heldman, Y ;
Fridkin, M ;
Katchalski-Katzir, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5164-5168
[6]   Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome [J].
Blank, M ;
Krause, I ;
Fridkin, M ;
Keller, N ;
Kopolovic, J ;
Goldberg, I ;
Tobar, A ;
Shoenfeld, Y .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (06) :797-804
[7]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[8]   AORTIC-INSUFFICIENCY AND MITRAL REGURGITATION IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROME [J].
CHARTASH, EK ;
LANS, DM ;
PAGET, SA ;
QAMAR, T ;
LOCKSHIN, MD .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04) :407-412
[9]   Structural basis for autoantibody recognition of phosphatidylserine-β2 glycoprotein I and apoptotic cells [J].
Cocca, BA ;
Seal, SN ;
D'Agnillo, P ;
Mueller, YM ;
Katsikis, PD ;
Rauch, J ;
Weigert, M ;
Radic, MZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13826-13831
[10]   MULTIPLE TRANSIENT ISCHEMIC ATTACKS, LUPUS ANTICOAGULANT AND VERRUCOUS ENDOCARDITIS [J].
DALTON, JG ;
PRESTON, DN ;
BORMANIS, J ;
GREEN, MS ;
KRAAG, GR .
STROKE, 1985, 16 (03) :512-514